|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
Q4 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaid deposits | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, less accumulated depreciation of $61,014 and $34,756 | ||||||||||||||||||||
| Deposit on building | ||||||||||||||||||||
| Warehouse building | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible properties | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Security deposit | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ (DEFICIENCY) | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Accrued payroll taxes and withholdings | ||||||||||||||||||||
| Accrued executive compensation | ||||||||||||||||||||
| Notes payable-third parties | ||||||||||||||||||||
| Debt discount | ||||||||||||||||||||
| Loans payable, related party | ||||||||||||||||||||
| Total loans payable, related party | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Common stock to be issued upon conversion of Series L Preferred Stock | ||||||||||||||||||||
| STOCKHOLDERS’ (DEFICIENCY): | ||||||||||||||||||||
| Preferred stock value | ||||||||||||||||||||
| Series L Preferred Stock | ||||||||||||||||||||
| Series N Preferred Stock | ||||||||||||||||||||
| Series P Preferred Stock | ||||||||||||||||||||
| Class A Common stock; 14,991,000,000 shares authorized, $.0001 par value, as of March 31, 2026 and June 30, 2025, there are 14,688,440,097 and 14,688,440,097 shares issued and outstanding, respectively | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Total class A Common stock; 14,991,000,000 shares authorized, $.0001 par value, as of March 31, 2026 and June 30, 2025, there are 14,688,440,097 and 14,688,440,097 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid- in capital Class A common stock | ||||||||||||||||||||
| Total additional paid- in capital Class A common stock | ||||||||||||||||||||
| Additional paid- in capital preferred stock | ||||||||||||||||||||
| Exchange shares to be issued | ||||||||||||||||||||
| Common stock to be issued | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Stockholders’ deficiency | ||||||||||||||||||||
| Total stockholders’ deficiency | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIENCY) | ||||||||||||||||||||
Loading...
